Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
True Materials is a biotechnology company that developed a proprietary platform for high-throughput single-cell analysis and sample preparation. The company's technology is designed to enhance the efficiency and scale of genomic and proteomic research by enabling more precise characterization of individual cells. In May 2024, True Materials was acquired by 10x Genomics to bolster its portfolio of single-cell and spatial biology solutions. The integration of True Materials' technology aims to streamline workflows for researchers in fields such as oncology, immunology, and drug discovery. Prior to its acquisition, the company operated in stealth mode, focusing on innovative approaches to sample preparation that reduce costs and increase throughput. This acquisition reflects 10x Genomics' strategy to continuously expand its capabilities in the rapidly evolving field of single-cell genomics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on True Materials.